Shinya Kimura - Search Results

Year	Number of Results
2002	5
2003	2
2004	5
2005	17
2006	11
2007	15
2008	19
2009	10
2010	20
2011	16
2012	16
2013	14
2014	22
2015	23
2016	27
2017	28
2018	38
2019	34
2020	48
2021	48
2022	29
2023	25
2024	6

1

Localization of Sites of Osimertinib Action in Rat Intestine, Skin, and Lung by Immunohistochemistry.

Yamamoto Y, Saita T, Kataoka H, Sogawa R, Kimura S, Kimura S, Shimanoe C, Shin M. Yamamoto Y, et al. Among authors: kimura s. Acta Histochem Cytochem. 2023 Dec 28;56(6):145-151. doi: 10.1267/ahc.23-00055. Epub 2023 Dec 23. Acta Histochem Cytochem. 2023. PMID: 38318107 Free PMC article.

2

Second Treatment-Free Remission Attempt in Patients with Chronic Myeloid Leukemia.

Ureshino H, Kamachi K, Kimura S. Ureshino H, et al. Among authors: kimura s. Clin Lymphoma Myeloma Leuk. 2024 Apr;24(4):e138-e141. doi: 10.1016/j.clml.2023.12.011. Epub 2023 Dec 29. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38195325 Review.

3

Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells.

Watanabe T, Yamamoto Y, Kurahashi Y, Kawasoe K, Kidoguchi K, Ureshino H, Kamachi K, Yoshida-Sakai N, Fukuda-Kurahashi Y, Nakamura H, Okada S, Sueoka E, Kimura S. Watanabe T, et al. Among authors: kimura s. Blood Adv. 2024 Mar 26;8(6):1345-1358. doi: 10.1182/bloodadvances.2023011131. Blood Adv. 2024. PMID: 38190613 Free PMC article.

4

In vitro evidence of synergistic efficacy with asciminib combined with reduced dose of ATP-binding pocket tyrosine kinase inhibitors according to the ABL1 kinase domain mutation profile.

Han HJ, Kim JJ, Pyne D, Travas A, Ambalavanan A, Kimura S, Deininger MW, Kim JW, Kim DDH. Han HJ, et al. Among authors: kimura s. Leukemia. 2024 Feb;38(2):412-415. doi: 10.1038/s41375-023-02122-5. Epub 2023 Dec 28. Leukemia. 2024. PMID: 38155246 No abstract available.

5

Thymic stromal lymphopoietin contributes to ozone-induced exacerbations of eosinophilic airway inflammation via granulocyte colony-stimulating factor in mice.

Kurihara Y, Tashiro H, Konomi Y, Sadamatsu H, Ihara S, Takamori A, Kimura S, Sueoka-Aragane N, Takahashi K. Kurihara Y, et al. Among authors: kimura s. Allergol Int. 2024 Apr;73(2):313-322. doi: 10.1016/j.alit.2023.12.002. Epub 2023 Dec 24. Allergol Int. 2024. PMID: 38145912 Free article.

6

Folate-Appended Hydroxypropyl-β-Cyclodextrin Induces Autophagic Cell Death in Acute Myeloid Leukemia Cells.

Kubota Y, Hoshiko T, Higashi T, Motoyama K, Okada S, Kimura S. Kubota Y, et al. Among authors: kimura s. Int J Mol Sci. 2023 Nov 24;24(23):16720. doi: 10.3390/ijms242316720. Int J Mol Sci. 2023. PMID: 38069042 Free PMC article.

7

Clinical PD-1/PD-L1 Blockades in Combination Therapies for Lymphomas.

Katsuya H, Suzumiya J, Kimura S. Katsuya H, et al. Among authors: kimura s. Cancers (Basel). 2023 Nov 14;15(22):5399. doi: 10.3390/cancers15225399. Cancers (Basel). 2023. PMID: 38001659 Free PMC article. Review.

8

Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

Hidaka M, Inokuchi K, Uoshima N, Takahashi N, Yoshida N, Ota S, Nakamae H, Iwasaki H, Watanabe K, Kosaka Y, Komatsu N, Meguro K, Najima Y, Eto T, Kondo T, Kimura S, Yoshida C, Ishikawa Y, Sawa M, Hata T, Horibe K, Iida H, Shimomura T, Dobashi N, Sugiura I, Makiyama J, Miyagawa N, Sato A, Ito R, Matsumura I, Kanakura Y, Naoe T. Hidaka M, et al. Among authors: kimura s. Jpn J Clin Oncol. 2024 Feb 7;54(2):153-159. doi: 10.1093/jjco/hyad156. Jpn J Clin Oncol. 2024. PMID: 37986553 Free PMC article.

9

Monitoring of blood levels in patients administered CYP3A4 inhibitor during the maintenance phase of venetoclax administration .

Kubo T, Matsuo S, Sogawa R, Yasu T, Nagaie T, Okamoto S, Kimura S, Shimanoe C. Kubo T, et al. Among authors: kimura s. Int J Clin Pharmacol Ther. 2024 Jan;62(1):56-60. doi: 10.5414/CP204490. Int J Clin Pharmacol Ther. 2024. PMID: 37969095

10

A Combination of Alectinib and DNA-Demethylating Agents Synergistically Inhibits Anaplastic-Lymphoma-Kinase-Positive Anaplastic Large-Cell Lymphoma Cell Proliferation.

Kawasoe K, Watanabe T, Yoshida-Sakai N, Yamamoto Y, Kurahashi Y, Kidoguchi K, Ureshino H, Kamachi K, Fukuda-Kurahashi Y, Kimura S. Kawasoe K, et al. Among authors: kimura s. Cancers (Basel). 2023 Oct 21;15(20):5089. doi: 10.3390/cancers15205089. Cancers (Basel). 2023. PMID: 37894456 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

403 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

403 results

Results by year